Literature DB >> 28330993

Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.

Matthijs J van Haren1, Nils Marechal2, Nathalie Troffer-Charlier2, Agostino Cianciulli3, Gianluca Sbardella3, Jean Cavarelli4, Nathaniel I Martin5.   

Abstract

Coactivator associated arginine methyltransferase 1 (CARM1) is a member of the protein arginine methyltransferase (PRMT) family and methylates a range of proteins in eukaryotic cells. Overexpression of CARM1 is implicated in a number of cancers, and it is therefore seen as a potential therapeutic target. Peptide sequences derived from the well-defined CARM1 substrate poly(A)-binding protein 1 (PABP1) were covalently linked to an adenosine moiety as in the AdoMet cofactor to generate transition state mimics. These constructs were found to be potent CARM1 inhibitors and also formed stable complexes with the enzyme. High-resolution crystal structures of CARM1 in complex with these compounds confirm a mode of binding that is indeed reflective of the transition state at the CARM1 active site. Given the transient nature of PRMT-substrate complexes, such transition state mimics represent valuable chemical tools for structural studies aimed at deciphering the regulation of arginine methylation mediated by the family of arginine methyltransferases.

Entities:  

Keywords:  CARM1; PRMT; cocrystal structures; protein arginine N-methyltransferase; transition state mimics

Mesh:

Substances:

Year:  2017        PMID: 28330993      PMCID: PMC5389282          DOI: 10.1073/pnas.1618401114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.

Authors:  Tanesha Osborne; Rachel L Weller Roska; Scott R Rajski; Paul R Thompson
Journal:  J Am Chem Soc       Date:  2008-03-14       Impact factor: 15.419

Review 2.  Protein arginine methyltransferases and cancer.

Authors:  Yanzhong Yang; Mark T Bedford
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

3.  Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.

Authors:  John S Sack; Sandrine Thieffine; Tiziano Bandiera; Marina Fasolini; Gerald J Duke; Lata Jayaraman; Kevin F Kish; Herbert E Klei; Ashok V Purandare; Pamela Rosettani; Sonia Troiani; Dianlin Xie; Jay A Bertrand
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

4.  Expression, purification, crystallization and preliminary crystallographic study of isolated modules of the mouse coactivator-associated arginine methyltransferase 1.

Authors:  Nathalie Troffer-Charlier; Vincent Cura; Pierre Hassenboehler; Dino Moras; Jean Cavarelli
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-03-30

5.  Differential CARM1 expression in prostate and colorectal cancers.

Authors:  Young-Rang Kim; Byung Kook Lee; Ra-Young Park; Nguyen Thi Xuan Nguyen; Jeong A Bae; Dong Deuk Kwon; Chaeyong Jung
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

6.  Crystal structure of the human PRMT5:MEP50 complex.

Authors:  Stephen Antonysamy; Zahid Bonday; Robert M Campbell; Brandon Doyle; Zhanna Druzina; Tarun Gheyi; Bomie Han; Louis N Jungheim; Yuewei Qian; Charles Rauch; Marijane Russell; J Michael Sauder; Stephen R Wasserman; Kenneth Weichert; Francis S Willard; Aiping Zhang; Spencer Emtage
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

7.  Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis.

Authors:  Shigehiro Osada; Shugo Suzuki; Chiaki Yoshimi; Miho Matsumoto; Tomoyuki Shirai; Satoru Takahashi; Masayoshi Imagawa
Journal:  Oncol Rep       Date:  2013-08-02       Impact factor: 3.906

Review 8.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

9.  Structural Insights into Ternary Complex Formation of Human CARM1 with Various Substrates.

Authors:  P Ann Boriack-Sjodin; Lei Jin; Suzanne L Jacques; Allison Drew; Chris Sneeringer; Margaret Porter Scott; Mikel P Moyer; Scott Ribich; Oscar Moradei; Robert A Copeland
Journal:  ACS Chem Biol       Date:  2015-11-23       Impact factor: 5.100

10.  Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes.

Authors:  Hongxia Cheng; Yejun Qin; Hui Fan; Peng Su; Xiaofang Zhang; Hui Zhang; Gengyin Zhou
Journal:  Diagn Pathol       Date:  2013-08-02       Impact factor: 2.644

View more
  11 in total

1.  Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.

Authors:  Dongxing Chen; Cheng Dong; Guangping Dong; Karthik Srinivasan; Jinrong Min; Nicholas Noinaj; Rong Huang
Journal:  J Med Chem       Date:  2020-07-16       Impact factor: 7.446

2.  Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors.

Authors:  Ludovic Halby; Nils Marechal; Dany Pechalrieu; Vincent Cura; Don-Marc Franchini; Céline Faux; Fréderic Alby; Nathalie Troffer-Charlier; Srikanth Kudithipudi; Albert Jeltsch; Wahiba Aouadi; Etienne Decroly; Jean-Claude Guillemot; Patrick Page; Clotilde Ferroud; Luc Bonnefond; Dominique Guianvarc'h; Jean Cavarelli; Paola B Arimondo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

3.  Exploring Unconventional SAM Analogues To Build Cell-Potent Bisubstrate Inhibitors for Nicotinamide N-Methyltransferase.

Authors:  Iredia D Iyamu; Jonah Z Vilseck; Ravi Yadav; Nicholas Noinaj; Rong Huang
Journal:  Angew Chem Int Ed Engl       Date:  2022-02-23       Impact factor: 15.336

4.  Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach.

Authors:  Giulia Iannelli; Ciro Milite; Nils Marechal; Vincent Cura; Luc Bonnefond; Nathalie Troffer-Charlier; Alessandra Feoli; Donatella Rescigno; Yalong Wang; Alessandra Cipriano; Monica Viviano; Mark T Bedford; Jean Cavarelli; Sabrina Castellano; Gianluca Sbardella
Journal:  J Med Chem       Date:  2022-04-28       Impact factor: 8.039

5.  A Direct Assay for Measuring the Activity and Inhibition of Coactivator-Associated Arginine Methyltransferase 1.

Authors:  Yurui Zhang; Matthijs J van Haren; Nils Marechal; Nathalie Troffer-Charlier; Vincent Cura; Jean Cavarelli; Nathaniel I Martin
Journal:  Biochemistry       Date:  2022-05-17       Impact factor: 3.321

6.  Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics.

Authors:  Yongzhi Gao; Matthijs J van Haren; Ned Buijs; Paolo Innocenti; Yurui Zhang; Davide Sartini; Roberto Campagna; Monica Emanuelli; Richard B Parsons; Willem Jespers; Hugo Gutiérrez-de-Terán; Gerard J P van Westen; Nathaniel I Martin
Journal:  J Med Chem       Date:  2021-08-23       Impact factor: 7.446

7.  Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors.

Authors:  Yurui Zhang; Nils Marechal; Matthijs J van Haren; Nathalie Troffer-Charlier; Vincent Cura; Jean Cavarelli; Nathaniel I Martin
Journal:  Chembiochem       Date:  2021-10-14       Impact factor: 3.461

8.  Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity.

Authors:  Yongzhi Gao; Matthijs J van Haren; Ed E Moret; Johannes J M Rood; Davide Sartini; Alessia Salvucci; Monica Emanuelli; Pierrick Craveur; Nicolas Babault; Jian Jin; Nathaniel I Martin
Journal:  J Med Chem       Date:  2019-07-12       Impact factor: 7.446

9.  Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4).

Authors:  Emma A Gunnell; Alaa Al-Noori; Usama Muhsen; Clare C Davies; James Dowden; Ingrid Dreveny
Journal:  Biochem J       Date:  2020-02-28       Impact factor: 3.857

10.  CARM1 methylates MED12 to regulate its RNA-binding ability.

Authors:  Donghang Cheng; Vidyasiri Vemulapalli; Yue Lu; Jianjun Shen; Sayura Aoyagi; Christopher J Fry; Yanzhong Yang; Charles E Foulds; Fabio Stossi; Lindsey S Treviño; Michael A Mancini; Bert W O'Malley; Cheryl L Walker; Thomas G Boyer; Mark T Bedford
Journal:  Life Sci Alliance       Date:  2018-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.